 | Up a level |
Grünberg, Jürgen; Lindenblatt, Dennis; Dorrer, Holger; Cohrs, Susan; Zhernosekov, Konstantin; Köster, Ulli; Türler, Andreas; Fischer, Eliane; Schibli, Roger (2014). Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. European journal of nuclear medicine and molecular imaging, 41(10), pp. 1907-1915. Springer 10.1007/s00259-014-2798-3
Müller, Cristina; Reber, Josefine; Haller, Stephanie; Dorrer, Holger; Bernhardt, Peter; Zhernosekov, Konstantin; Türler, Andreas; Schibli, Roger (2014). Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate. European journal of nuclear medicine and molecular imaging, 41(3), pp. 476-485. Springer 10.1007/s00259-013-2563-z
Müller, Cristina; Reber, Josefine; Haller, Stephanie; Dorrer, Holger; Köster, Ulli; Johnston, Karl; Zhernosekov, Konstantin; Türler, Andreas; Schibli, Roger (2014). Folate Receptor Targeted Alpha-Therapy Using Terbium-149. Pharmaceuticals, 7(3), pp. 353-365. MDPI 10.3390/ph7030353
Müller, Christina; Zhernosekov, Konstantin; Köster, Ulli; Johnston, Karl; Dorrer, Holger; Hohn, Alexander; van der Walt, Nico T.; Türler, Andreas; Schibli, Roger (2012). A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β−-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative. Journal of nuclear medicine, 53(12), pp. 1951-1959. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.112.107540
